Search This Blog

Thursday, May 31, 2018

Cantel Medical trims FY18 sales growth outlook to 12.5%-13.0%


Cantel Medical in earnings call presentation slides lowered its sales growth outlook for fiscal 2018 to 12.5%-13.0% from 13.0%-14.0%. Sales are at the lower end of the company’s guidance for fiscal year 2018 and in line with its five-year strategic plan, it noted. Cantel revised its fiscal 2018 earnings per share outlook to $2.47-$2.50. The company sees a net tax benefit for the year of 14c-15c. Shares of Cantel Medical are down 8% to $119.81 in morning trading.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.